274 related articles for article (PubMed ID: 24627597)
1. Non-invasive prediction of forthcoming cirrhosis-related complications.
Kang W; Kim SU; Ahn SH
World J Gastroenterol; 2014 Mar; 20(10):2613-23. PubMed ID: 24627597
[TBL] [Abstract][Full Text] [Related]
2. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease.
Park MS; Han KH; Kim SU
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):501-11. PubMed ID: 24939348
[TBL] [Abstract][Full Text] [Related]
4. A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.
Boursier J; de Ledinghen V; Leroy V; Anty R; Francque S; Salmon D; Lannes A; Bertrais S; Oberti F; Fouchard-Hubert I; Calès P
J Hepatol; 2017 Jun; 66(6):1158-1165. PubMed ID: 28088581
[TBL] [Abstract][Full Text] [Related]
5. Quantitative fibrosis estimation by image analysis predicts development of decompensation, composite events and defines event-free survival in chronic hepatitis B patients.
Bihari C; Rastogi A; Sen B; Bhadoria AS; Maiwall R; Sarin SK
Hum Pathol; 2016 Sep; 55():63-71. PubMed ID: 27189343
[TBL] [Abstract][Full Text] [Related]
6. Non invasive tools for the diagnosis of liver cirrhosis.
Soresi M; Giannitrapani L; Cervello M; Licata A; Montalto G
World J Gastroenterol; 2014 Dec; 20(48):18131-50. PubMed ID: 25561782
[TBL] [Abstract][Full Text] [Related]
7. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
[TBL] [Abstract][Full Text] [Related]
8. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
Resino S; Bellón JM; Asensio C; Micheloud D; Miralles P; Vargas A; Catalán P; López JC; Alvarez E; Cosin J; Lorente R; Muñoz-Fernández MA; Berenguer J
BMC Infect Dis; 2010 Aug; 10():244. PubMed ID: 20723207
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive assessment of liver fibrosis in chronic hepatitis B.
Branchi F; Conti CB; Baccarin A; Lampertico P; Conte D; Fraquelli M
World J Gastroenterol; 2014 Oct; 20(40):14568-80. PubMed ID: 25356021
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
Stål P
World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
[TBL] [Abstract][Full Text] [Related]
11. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.
Siddiqui MS; Patidar KR; Boyett S; Luketic VA; Puri P; Sanyal AJ
Liver Int; 2016 Apr; 36(4):572-9. PubMed ID: 26713759
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
[TBL] [Abstract][Full Text] [Related]
13. Evolving strategies for liver fibrosis staging: Non-invasive assessment.
Stasi C; Milani S
World J Gastroenterol; 2017 Jan; 23(2):191-196. PubMed ID: 28127192
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
17. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
18. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis.
Kim SU; Oh HJ; Wanless IR; Lee S; Han KH; Park YN
J Hepatol; 2012 Sep; 57(3):556-63. PubMed ID: 22617153
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
[TBL] [Abstract][Full Text] [Related]
20. Quick chronic liver failure-sequential organ failure assessment: an easy-to-use scoring model for predicting mortality risk in critically ill cirrhosis patients.
Zhou XD; Zhang JY; Liu WY; Wu SJ; Shi KQ; Braddock M; Chen YP; Huang WJ; Zheng MH
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):698-705. PubMed ID: 28240612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
